


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+6.87%
+0.83%
+1.37%
+5.22%
+2.26%
PCVX
Vaxcyte
$49.08
Strengths

Upgraded on attractively valued
Chart
$44.57 (+10.12%)
$30.79 (+59.40%)
$33.25 (+47.61%)
$93.39 (-47.45%)
PCVX has Fair risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

PCVX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
![]()
PCVX Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PCVX Street Sentiment is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is PCVX current stock price?
What are PCVX stock strengths?
What is PCVX Risk Level?
What is PCVX market cap and volume?
What is PCVX current Stock IQ?
Should I buy PCVX stock right now?
Is PCVX a Strong Buy right now?
What does a 'Strong Buy' rating mean for PCVX?
What does a 'Strong Sell' rating mean for PCVX?
What factors influence PCVX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+6.87%
+0.83%
+1.37%
+5.22%
+2.26%
PCVX
Vaxcyte
Current Price
$49.08
Stock Insights
Strengths

Upgraded on attractively valued

Chart
$44.57 (+10.12%)
$30.79 (+59.40%)
$33.25 (+47.61%)
$93.39 (-47.45%)
PCVX Analysts Opinion
PCVX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
![]()
PCVX Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PCVX Street Sentiment is extremely bullish and have negative views on the near-term outlook
PCVX has Fair risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels.
PCVX Latest Analysis
TD Cowen Reiterates Buy Rating on Vaxcyte (PCVX) With $50 PT. With significant upside potential and hedge fund interest Vaxcyte Inc. (NASDAQ:PCVX) secured a spot on our list of the 15 stocks set to explode in 2026. On November 5 2025 TD Cowen analyst Tara Bancroft reiterated her Buy rating on Vaxcyte Inc. (NASDAQ:PCVX) with a $50 price target. The analyst cited positive Phase II data [….]
Tue Nov 11, 2025
BTIG Reiterates Vaxcyte (PCVX) Buy Recommendation. Fintel reports that on November 10 2025 BTIG reiterated coverage of Vaxcyte (NasdaqGS:PCVX) with a Buy recommendation. Analyst Price Forecast Suggests 143.06% Upside
Mon Nov 10, 2025
Vaxcyte GAAP EPS of -$1.56 misses by $0.25.
Tue Nov 4, 2025
Vaxcyte Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Data from Positive VAX-24 Infant Phase 2 Dose-Finding Study. Final Data from VAX-24 Infant Phase 2 Dose-Finding Study Consistent with Previously Reported Positive Interim Data. Provide Additional Evidence Supporting Higher VAX-31 Doses Being Evaluated in Ongoing Infant Phase 2 Study
Tue Nov 4, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
PCVX Stock trends
PCVX Stock performance
PCVX Stock analysis
PCVX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.